These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25299469

  • 1. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy.
    Jung JS, Lee SM, Kim SJ, Choi J, Han SW.
    Nucl Med Commun; 2015 Jan; 36(1):38-44. PubMed ID: 25299469
    [Abstract] [Full Text] [Related]

  • 2. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
    Aydin F, Sipahi M, Budak ES, Oner AO, Demirelli S, Erkilic M, Gungor F.
    Ann Nucl Med; 2016 Jan; 30(1):60-7. PubMed ID: 26462671
    [Abstract] [Full Text] [Related]

  • 3. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
    Thientunyakit T, Pusuwan P, Tuchinda P, Khiewvan B.
    J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
    [Abstract] [Full Text] [Related]

  • 4. Role of Tc-99m pertechnetate for remnant scintigraphy post-thyroidectomy.
    Kueh SS, Roach PJ, Schembri GP.
    Clin Nucl Med; 2010 Sep; 35(9):671-4. PubMed ID: 20706039
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities.
    Giovanella L, Paone G, Ruberto T, Ceriani L, Trimboli P.
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
    [Abstract] [Full Text] [Related]

  • 6. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
    Ozdemir D, Cuhaci FN, Ozdemir E, Aydin C, Ersoy R, Turkolmez S, Cakir B.
    Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan.
    Hommel I, Pieters GF, Rijnders AJ, van Borren MM, de Boer H.
    Neth J Med; 2016 May; 74(4):152-7. PubMed ID: 27185773
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer.
    Lee SW, Lee J, Lee HJ, Seo JH, Kang SM, Bae JH, Ahn BC.
    Thyroid; 2007 Apr; 17(4):341-6. PubMed ID: 17465864
    [Abstract] [Full Text] [Related]

  • 13. Sufficiency of a Single Negative Thyroglobulin Standard for Judging the Success of Ablation in Low- and Intermediate-risk Differentiated Thyroid Cancer: A Retrospective Study.
    Long Y, Jin J, Zhang W.
    Endocr Metab Immune Disord Drug Targets; 2024 Apr; 24(10):1204-1214. PubMed ID: 38192150
    [Abstract] [Full Text] [Related]

  • 14. Pyramidal lobe decreases endogenous TSH stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer.
    Sawicka-Gutaj N, Klimowicz A, Sowinski J, Oleksa R, Gryczynska M, Wyszomirska A, Czarnywojtek A, Ruchala M.
    Ann Endocrinol (Paris); 2014 Jul; 75(3):141-7. PubMed ID: 24997767
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
    Lee SM, Lee JW, Kim SY, Han SW, Bae WK.
    Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
    Lee HJ, Rha SY, Jo YS, Kim SM, Ku BJ, Shong M, Kim YK, Ro HK.
    Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of 99mTc-pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry.
    Nadig MR, Pant GS, Bal C.
    Nucl Med Commun; 2008 Sep; 29(9):809-14. PubMed ID: 18677209
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy.
    de Klerk JM, de Keizer B, Zelissen PM, Lips CM, Koppeschaar HP.
    Nucl Med Commun; 2000 Jun; 21(6):529-32. PubMed ID: 10894561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.